Braidwell’s Outset Medical OM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-46,302
Closed -$2.67M 86
2024
Q2
$2.67M Sell
46,302
-113,726
-71% -$5.57M 0.08% 73
2024
Q1
$5.33M Hold
160,028
0.17% 68
2023
Q4
$13M Hold
160,028
0.48% 52
2023
Q3
$26.1M Buy
160,028
+62,670
+64% +$14.8M 0.83% 43
2023
Q2
$31.9M Sell
97,358
-19,599
-17% -$5.98M 1.04% 35
2023
Q1
$32.3M Buy
116,957
+3,320
+3% +$1.22M 1.06% 35
2022
Q4
$44M Buy
+113,637
New +$32M 1.47% 23

Other funds holding OM

Braidwell's OM Position: Q3 2024 in Review

Braidwell sold out of Outset Medical (OM) in Q3 2024, closing a stake of 46,302 shares — an estimated $2.67M sold.

Braidwell first reported a position in OM in Q4 2022 and held it in 7 quarters. The position peaked at $44M in Q4 2022. 78 funds tracked by Wall St. Rank hold OM as of Q3 2024.

  • Braidwell reported no remaining Outset Medical position as of Q3 2024 after selling out during the quarter.
  • Braidwell sold 46,302 Outset Medical shares in Q3 2024, an estimated $2.67M.
  • Braidwell first reported a position in Outset Medical in Q4 2022 and held it in 7 quarters.
  • Braidwell's Outset Medical position peaked at $44M in Q4 2022.
  • 78 funds tracked by Wall St. Rank held Outset Medical as of Q3 2024.

Based on Braidwell's 13F filing for Q3 2024, filed 14 Nov 2024.